/
   Retroperitoneal Sarcoma (RPS)    Retroperitoneal Sarcoma (RPS)

Retroperitoneal Sarcoma (RPS) - PowerPoint Presentation

olivia-moreira
olivia-moreira . @olivia-moreira
Follow
342 views
Uploaded On 2020-04-05

Retroperitoneal Sarcoma (RPS) - PPT Presentation

High Risk Gross Tumor Volume Boost HR GTV Boost Contour Delineation Agreement among RTOG Sarcoma Radiation and Surgical Oncologists Elizabeth H Baldini MD MPH DanaFarber Cancer InstituteBrigham and Womens Hospital ID: 775716

gtv agreement volume boost gtv agreement volume boost contour rps radiation risk target tumor surgical volumes high teams red

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " Retroperitoneal Sarcoma (RPS) " is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Retroperitoneal Sarcoma (RPS) High Risk Gross Tumor Volume Boost (HR GTV Boost) Contour Delineation Agreement among RTOG Sarcoma Radiation and Surgical Oncologists Elizabeth H Baldini MD, MPHDana-Farber Cancer Institute/Brigham and Women’s Hospital

CTOS

October 16, 2014

Slide2

Contributing Authors

E Baldini, C RautD Wang, R Abrams, K MillikanK Salerno, J KaneC Deville, G KarakousisI Petersen, M KendrickT DeLaney, Y Chen, J MullenW Bosch

Dana-Farber/Brigham & Women’sRush University Medical CenterRoswell Park Cancer InstituteUniversity of PennsylvaniaMayo ClinicMassachusetts General HospitalWashington University

Supported by grants U10CA21661, U10CA180868, U10CA180822

,

U10CA37422

, U24CA180803 from the National Cancer Institute

Slide3

Background

Only proven curative intent treatment modality for RPS is surgeryRole of pre-op RT has not been proven and is the subject of a randomized trial: EORTC STRASS 62092In the meantime, many multi-disciplinary teams employ pre-op RT for RPS and consensus guidelines have been developed for delineation of RT target volumes*

*CTOS, New York, 2013

Slide4

Background

Further, there is interest in delivering a “boost” dose of RT to high risk areas of the tumor volume judged to be at risk for positive margins following resectionThis is being tested in a multi-center Phase I/II trial among several US NRG institutions (PI: DeLaney)

Gross Tumor

Volume(GTV)

High Risk Boost Volume

Slide5

Radiation Target Volume Definitions

GTV: Gross Tumor VolumeCTV: Clinical Target Volume- GTV plus adjacent areas of potential microscopic diseaseHigh Risk GTV (HR GTV): Area of GTV judged to be at high risk of positive margins after resection

GTV: red

CTV: yellow

GTV: red

HR GTV: pink

Slide6

Background

Target VolumeKappa AgreementRPS1RPS2Gross Tumor Volume(GTV)0.84 Almost Perfect0.92 Almost PerfectClinical Target Volume(CTV)0.79 Substantial0.86 Almost PerfectHR Boost Volume0.50 Moderate0.57 Moderate

HR Boost Volume contour agreement was suboptimal More clarification of this boost target volume is needed Basis of the current project

Variability of RPS target volume contour delineation among Sarcoma Radiation Oncologists has recently been assessed**

**ASTRO, San Francisco, 2014

Slide7

Purpose

To evaluate the variability in HR GTV Boost target volume delineation among sarcoma radiation and surgical oncology teams

Slide8

Methods

Radiation planning CT scans for 3 cases of RPS were distributed to 7 radiation and surgical oncology teams

GTV (gross tumor volume) and organ contours were provided

Teams were asked to contour HR GTV Boost volumes for each case

Slide9

HR GTV Boost Contour Instructions

Area considered to be at high risk for positive margins following resectionGenerally areas of tumor located along posterior RP musculature, ipsilateral pre-vertebral space, major vessels, or organs the surgeon would leave in situContour 1.5 cm thick 

High Risk Boost Volume

GTV

Slide10

Methods: Analysis of Contour Agreement

Simultaneous truth and performance level estimation (STAPLE) algorithm* Kappa statistics (yield values from -1 to +1)Kappa = -1 : complete disagreementKappa = +1 : complete agreementDescriptive categories for interpretation of strength** Kappa < 0 is poor 0.00 - 0.20 is slight 0.21 - 0.40 is fair 0.41 - 0.60 is moderate 0.61 - 0.80 is substantial 0.81 - 1.00 is almost perfect agreement

*Warfield, IEEE Transactions on Medical Imaging 2004;23:903

** Landis, Biometrics 1977;33:159

Slide11

Results

Each case was contoured by 7 radiation and surgical oncology teams

First case: RPS 1

De-differentiated (DD) liposarcoma (LPS) of right upper quadrant

Second case: RPS 2

Leiomyosarcoma (LMS) of left upper quadrant

Third case: RPS 3

DD LPS of left lower quadrant with extension through inguinal canal into upper scrotum

Slide12

Results HR GTV Boost Volume Contour Agreement

Kappa AgreementRPS 1: DD LPS right upper quadrant0.66 ModerateRPS 2: LMS left upper quadrant0.61 ModerateRPS 3: DD LPS left lower quadrant0.52 Moderate

Slightly better agreement than prior consensus project (0.50, 0.57)

Contour agreement for all cases was only moderate

Slide13

HR GTV: Very Good Agreement

RPS 2: LUQ LMS

Very good contour agreement laterally along chest wall and medially along ipsilat para-vertebral space and aorta

Red: GTV

Other colors: HR GTV volumes

Slide14

HR GTV: Marginal Agreement

Red: GTV

Other colors: HR GTV volumes

RPS 3: LLQ DD LPS

Marginal

contour agreement medially along bladder and

anteriorly

along anterior abdominal wall

Slide15

HR GTV: Marginal Agreement

Red: GTVOther colors: HR GTV volumes

RPS 1:RUQ DD LPSMarginal agreement along liver 4 contours include entire liver surface in contact with tumor, 3 contours exclude liver

Slide16

Conclusion

Overall agreement for HR GTV boost volumes was moderate

Contour agreement was best:

Postero

-laterally, abutting chest wall

Medially, abutting RP musculature, ipsilateral para-vertebral space, great vessels

Contour agreement most variable:

Abutting organs such as liver and bladder

Discrepancies are explained by differing surgical opinions regarding partial organ resections for these cases

Highlights extreme importance of collaboration between radiation and surgical oncologist for each patient

Slide17

Future Directions

Further discussion among sarcoma radiation and surgical oncologists is needed to reach improved consensus

An atlas with detailed examples of HR GTV volumes may be an effective educational tool